Awakn Life Sciences Corp. Announces Completion of Reverse Takeover Transaction, Release from Escrow of Private Placement Proceeds, and Final Approval for Listing on Neo Exchange Psychedelics Investing
Bristol Myers Squibb Receives European Commission Approval for Onureg® as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia Biotech Investing
Naturally Splendid Purchases Packaging Line and Announces Shares for Debt Transaction Biotech Investing
Canbud Distribution Enters into Definitive Agreement to Acquire Molecular Science Corp. Agriculture Investing
Silo Wellness and Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Announces Psychedelics Genetic Test Kit Partnership Psychedelics Investing
Eisai and Bristol Myers Squibb Enter Into Global Strategic Collaboration for Eisai's MORAb-202 Antibody Drug Conjugate Biotech Investing
